Return On Equity of Entrada Therapeutics, Inc. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Entrada Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • Entrada Therapeutics, Inc. Return On Equity for the quarter ending 31 Dec 2025 was -40%, a 335% decline year-over-year.
  • Entrada Therapeutics, Inc. annual Return On Equity for 2025 was -40%, a 335% decline from 2024.
  • Entrada Therapeutics, Inc. annual Return On Equity for 2024 was 17%.
  • Entrada Therapeutics, Inc. annual Return On Equity for 2023 was -2.9%, a 93% increase from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Entrada Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2025 -40% -57% -335% 01 Oct 2025 31 Dec 2025
Q3 2025 -26% -43% -264% 01 Jul 2025 30 Sep 2025
Q2 2025 -18% -53% -151% 01 Apr 2025 30 Jun 2025
Q1 2025 5.8% -3.9% -40% 01 Jan 2025 31 Mar 2025
Q4 2024 17% +20% 01 Oct 2024 31 Dec 2024
Q3 2024 16% +26% 01 Jul 2024 30 Sep 2024
Q2 2024 35% +72% 01 Apr 2024 30 Jun 2024
Q1 2024 9.7% +44% 01 Jan 2024 31 Mar 2024
Q4 2023 -2.9% +36% +93% 01 Oct 2023 31 Dec 2023
Q3 2023 -9.7% +23% +71% 01 Jul 2023 30 Sep 2023
Q2 2023 -37% +3.6% +8.8% 01 Apr 2023 30 Jun 2023
Q1 2023 -34% +24% +41% 01 Jan 2023 31 Mar 2023
Q4 2022 -39% +136% +78% 01 Oct 2022 31 Dec 2022
Q3 2022 -33% -108% -145% 01 Jul 2022 30 Sep 2022
Q2 2022 -41% -115% -155% 01 Apr 2022 30 Jun 2022
Q1 2022 -58% -138% -172% 01 Jan 2022 31 Mar 2022
Q4 2021 -174% -262% -298% 01 Oct 2021 31 Dec 2021
Q3 2021 74% 01 Jul 2021 30 Sep 2021
Q2 2021 74% 01 Apr 2021 30 Jun 2021
Q1 2021 80% 01 Jan 2021 31 Mar 2021
Q4 2020 88% 01 Oct 2020 31 Dec 2020

Entrada Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2025 -40% -57% -335% 01 Jan 2025 31 Dec 2025
2024 17% +20% 01 Jan 2024 31 Dec 2024
2023 -2.9% +36% +93% 01 Jan 2023 31 Dec 2023
2022 -39% +136% +78% 01 Jan 2022 31 Dec 2022
2021 -174% -262% -298% 01 Jan 2021 31 Dec 2021
2020 88% 01 Jan 2020 31 Dec 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.